International Journal of Clinical Oncology

Article	Citations
The cancer‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma	139
Macroscopic and multiple metastases in sentinel lymph node biopsy are respectively associated with poor prognosis in early oral cancer	73
Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter prospective trial	56
What has changed in malignant mesothelioma between 1990 and 2019? A time- series analyses in Turkey	47
Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy	45
Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution	43
The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan	37
Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer	34
Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy	34
Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer	32
Impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy	30
Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers	29
Prognostic significance of adjuvant chemotherapy in stage I–II endometrial carcinoma patients who underwent lymphadenectomy	28
Identification of clinical prognosis features and significant DNA methylation regulation in pineoblastoma	27
Real-world application of comprehensive genomic profiling for gynecological malignancies: a multicenter observational study	27
Can contralateral lymph-node metastases be ruled out in prostate cancer patients with only unilaterally positive prostate biopsy?	26
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience	26
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity	25
Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study	24
Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis	24
Efficacy and safety of adjuvant nivolumab after radical surgery for high-risk urothelial carcinoma: a preliminary report of real-world data from a single institution	23
Correction to: An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors	22
Comparison of treatment outcomes of pelvis external radiotherapy with and without vaginal brachytherapy for cervical cancer patients with positive or close vaginal resected margins	22
Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines fo	22
Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701	21

The correlation of immunoscore and frailty in colorectal cancer	20
Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer	19
Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis	19
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational	19
Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan	19
Clinical utility of artificial intelligence assistance in histopathologic review of lymph node metastasis for gastric adenocarcinoma	18
Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection of brain metastasis: a case series of 20 patients	18
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of alectinib and pembrolizumab for the adjuvant treatment of non-small cell lung cancer in Japa	18
High incidence of immune checkpoint inhibitor-induced pneumonitis in patients with non-small cell lung cancer and interstitial pneumonia, regardless of honeycomb lung or forced vital capacity: results	18
The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study	18
Carcinogenesis and management of human papillomavirus-associated cervical cancer	18
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study	17
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer	17
New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm	17
The efficacy of albumin–globulin ratio to predict prognosis in cancer patients	17
Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance	16
The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis	16
The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone	16
Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patient	16
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies	16
Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy	16
The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer	15
Potential intrinsic subtype dependence on the association between metformin use and survival in surgically resected breast cancer: a Korean national population-based study	15
Advantages and limitations of estrogen replacement therapy on hypogonadal survivors of childhood cancer	15
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study	15
Correction: The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis	14
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation	14
Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data	14
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer	13
Functional outcomes at PICU discharge in hemato-oncology children at a tertiary oncology center in Hong Kong	13
How to report and discuss subgroup analyses in clinical practice guidelines? Evaluation procedure of the clinical and statistical relevancy	13
Comparison of the efficacy of enfortumab vedotin and paclitaxel plus carboplatin in patients with metastatic urothelial carcinoma	13
Overweight and obesity as risk factors for biochemical recurrence of prostate cancer after radical prostatectomy	13
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023	13
Severe weight loss during PD-1 treatment is a risk sign of poor prognosis for advanced GC patients	13
An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors	13
List of reviewers 2022–2023	13
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022	13
Electronic patient-reported outcomes as digital therapeutics for patients with cancer: a narrative review of current practices and future directions	13
Association of microbiota with cancer treatment	13
CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resection	12
Glomerular filtration rate measurement during platinum treatment for urothelial carcinoma: optimal methods for clinical practice	12
Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin–bilirubin grade	12
Investigation of tumor mutation burden using the comprehensive genomic profiling data of vulvar and vaginal malignant tumors: an observational study using C-CAT database	12
Human papillomavirus testing and cytology using physician-collected uterine cervical samples vs. self-collected vaginal samples and urine samples	12
The curse of blood–brain barrier and blood–tumor barrier in malignant brain tumor treatment	12
Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405)	12
Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer	12
Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan	12
Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy	12

Personalized prognostic model for colorectal cancer in the era of precision medicine: a dynamic approach based on real-world data	12
Muscle strength and functional recovery for soft-tissue sarcoma of the thigh: a prospective study	12
Prognostic laboratory score to predict 14-day mortality in terminally ill patients with respiratory malignancy	12
Robotic dual-docking surgery for para-aortic lymphadenectomy in endometrial cancer: a prospective feasibility study	12
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of sacituzumab govitecan for breast cancer, fruquintinib for colorectal cancer, amivantamab for	12
Risk assessment of multi-factorial complications after transrectal ultrasound-guided prostate biopsy: a single institutional retrospective cohort study	11
Real-world data on the efficacy and safety of adjuvant chemotherapy in Japanese patients with a high-risk of gastrointestinal stromal tumor recurrence	11
Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study	11
Trends in incidence and hormonal management of endometrial cancer during potentially reproductive age in Japan: a population-based study	11
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in pati	11
Artificial intelligence predicts lymph node metastasis or risk of lymph node metastasis in T1 colorectal cancer	11
Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113	11
Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer	11
Discovery and validation of Hsa-microRNA-3665 promoter methylation as a potential biomarker for the prognosis of esophageal squaous cell carcinoma	11
The influence of UGT1A1 polymorphisms on modified FOLFIRINOX dose in double-variant-type patients with advanced pancreatic cancer	11
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies	11
Different outcomes by sex in metastatic gastrointestinal stromal tumor patients receiving imatinib: a trial-level analysis	11
Impact of time to first relapse on long-term outcome in adult retroperitoneal sarcoma patients after radical resection	11
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turk	10
Association of chromosome 2 open reading frame 71 in colorectal cancer susceptibility	10
Tolerability and safety of adjuvant chemoradiotherapy with S-1 after limited surgery for T1 or T2 lower rectal cancer	10
A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice	10
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2	10
Current status of AYA-generation breast cancer: trends worldwide and in Japan	10
Clinical outcomes of sentinel node navigation surgery in patients with preoperatively estimated stage IA endometrial cancer and evaluation of validity for continuing sentinel node navigation surgery b	10
Impact of prostate-specific antigen screening on tumor size in patients with prostate cancer in a super-aging district in Kyoto, Japan	10
Risk factors affecting delay of initiating adjuvant chemotherapy for stage III colorectal cancer	10
Correction to: Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study	10
Conversion surgery for esophageal and esophagogastric junction cancer	10
Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma	10
Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome	10
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for gastric and biliary tract cancer and encorafenib and binimetinib for thyro	9
PIV and PILE scores predict the clinical outcome in patients with metastatic breast cancer treated with CDK4/6 inhibitors	9
A novel 5-differentially expressed gene (DEG) signature predicting the prognosis in patients with metastatic liver malignancies and the prognostic and therapeutic potential of SPP1	9
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systemati	9
Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapy	9
Utility of whole exome sequencing analysis in differentiating intrapulmonary metastatic multiple ground-glass nodules (GGNs) from multiple primary GGNs	9
Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study	9
Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis	9
Safety and pharmacokinetics of vepdegestrant in Japanese patients with ER+ advanced breast cancer: a phase 1 study	9
Utility of comprehensive genomic profiling combined with machine learning for prognostic stratification in stage II/III colorectal cancer after adjuvant chemotherapy	9
Physical activity and cancer biology: a narrative review of molecular mechanisms and introduction of the SCRUM-MONSTAR LIFELOG study	9
EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system	9
Stereotactic body radiotherapy for oligometastatic disease: current evidence and future perspectives	8
The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases—a literature review	8
Comparison of clinical outcomes between androgen deprivation therapy with up-front abiraterone and bicalutamide for Japanese patients with LATITUDE high-risk prostate cancer in a real-world retrospect	8
Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi‐institutional analysis	8
Distribution of Geriatric 8 screening tool scores in elderly and non-elderly patients with cancer	8
Clinical utility of a comprehensive genomic profiling test for patient with advanced biliary tract cancer	8
Lynch syndrome screening in patients with young-onset extra-colorectal Lynch syndrome-associated cancers	8
Urological cancer statistics on incidence from 1975 to 2019 and mortality from 1958 to 2022 in Japan	8
Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG1	8
Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106)	8
CT-derived skeletal muscle change before immunotherapy predicts survival of advanced gastric cancer: associations with inflammatory markers and liver lipid metabolism	8
Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1	8
Characteristics of gut microbiota in high-methylated colorectal cancer	8
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of atezolizumab for alveolar soft part sarcoma, epcoritamab for follicular lymphoma, and isatux	8
Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data	8
Outcomes of cases with complete hydatidiform mole coexisting with a fetus: a single-center study	8
Clinical outcomes of brain metastasectomy from soft tissue and bone sarcomas: a systematic review	8
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab	8
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study	8
Current state of fertility preservation for adolescent and young adult patients with gynecological cancer	8
Usefulness of dual isotope 123I-IMP and 201Tl SPECT for the diagnosis of primary central nervous system lymphoma and glioblastoma	8
Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancer	8
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma	7
Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy	7
Revisiting resectability of biliary tract cancers, in the triplet drug therapy era with immune checkpoint inhibitors	7
Clinical course of longer than five years after definitive radiotherapy for nasopharyngeal carcinoma	7
Correction to: Negative prognostic outcomes of percutaneous transhepatic biliary drainage in distal cholangiocarcinoma: a retrospective analysis using propensity score matching	7
Oncology drug lag in Japan: has it improved over the last decade?	7
Systematic review and meta-analysis of photon radiotherapy versus proton beam therapy for pediatric rhabdomyosarcoma: TRP-rhabdomyosarcoma 2024	7
Clinical and oncologic outcomes of laparoscopic versus open surgery in elderly patients with colorectal cancer: a retrospective multicenter study	7
Lower accuracy of cytological screening for high-grade squamous intraepithelial neoplasia in women over 50 years of age in Japan	7
Systematic surveillance of immune-related adverse events in clinical practice and impact of subsequent steroid medication on survival outcomes	7
Association between hospital palliative care team intervention volume and patient outcomes	7
Diagnostic performance of TILs–US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer	7
The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study	7
Phase 1 study evaluating safety and pharmacokinetics of tusamitamab ravtansine monotherapy in Japanese patients with advanced malignant solid tumors	7
Identification of Lynch syndrome-associated DNA mismatch repair-deficient bladder cancer in a Japanese hospital-based population	7

Surveillance of radical hysterectomy for early-stage cervical cancer in the early experienced period of minimally invasive surgery in Japan	7
Changes of cancer diagnosis disclosure to children in Japan in the last 20 years	7
COVID-19 infection in pediatric patients treated for cancer	7
Current clinical perspective of urological oncology in the adolescent and young adult generation	7
Clinicopathological characteristics of four major histological types of high-grade parotid carcinoma	7
Establishment of nedaplatin safety dose formula based on renal function for combination chemotherapy with nedaplatin and 5-fluorouracil in patients with esophageal cancer	7
Comparison of perioperative outcomes and complications between intracorporeal, extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted radical cystectomy: a comparative propen	7
Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma	7
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of	7
Concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with head and neck squamous cell carcinoma: survival analysis based on 2-year follow-up data	7
Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF	7
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022	7
Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy	6
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)	6
Prognostic value of PSA bounce after definitive radiotherapy revisited	6
Treatments for elderly cancer patients and reforms to social security systems in Japan	6
Comparison of survival outcomes of abdominal radical hysterectomy and radiochemotherapy IIA2 (FIGO2018) cervical cancer: a retrospective study from a large database of 63,926 cases of cervical cancer	6
Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data	6
Clinical advantage of transmediastinal esophagectomy in terms of postoperative respiratory complications	6
Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan	6
Clinical factors predicting the outcome of salvage radiotherapy for patients with biochemical recurrence after radical prostatectomy	6
Survey of healthcare professionals’ awareness of appearance care for Japanese cancer patients and their institutions’ appearance care systems: report from the Japan Society of Clinical Oncology	6
Prognostic factors and management of elderly sarcoma in Japan: the population-based National Cancer Registry (NCR) in Japan	6
Rubicon can predict prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant chemoradiotherapy	6
Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study	6
Current advances and challenges in minimally invasive esophagectomy	6
Long-term outcomes of D2 vs. D3 lymph node dissection for cT2N0M0 colorectal cancer: a multi‑institutional retrospective analysis	6
Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer	6
Immune checkpoint inhibitors in the treatment of pleural mesothelioma: insights from real-world data	6
The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma	6
New therapeutic target molecules for gastric and gastroesophageal junction cancer	6
Effect of a web-based fertility preservation training program for medical professionals in Japan	6
An approach for improvement of the accuracy of cancer gene panel testing	6
High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer	6
Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)	6
Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study	6
A phase two trial evaluating FOLFIRI plus aflibercept after failure of FOLFOXIRI plus bevacizumab in patients with unresectable metastatic colorectal cancer	6
Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022	6
Correction to: Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gyneco	6
Correction to: Risk of first onset of colorectal cancer associated with alcohol consumption in Lynch syndrome: a multicenter cohort study	6
Status of cervical cancer screening among adolescents and young adults (AYA) in Japan	6
First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048	6
Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab	6
Fusobacterium nucleatum load in MSI colorectal cancer subtypes	6
Local excision versus radical surgery for anal squamous cell carcinoma: a multicenter study in Japan	6
Correction to: Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan	6
Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer	6
Advances in the treatment of human epidermal growth factor receptor 2-positive gastric cancer	5
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF	5
Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis	5
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801	5
Prognostic impact and survival outcomes of colon perforation in patients with metastatic colorectal cancer: a multicenter retrospective cohort study	5
Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients	5
Novel combined fibrosis-based index predicts the long-term outcomes of hepatocellular carcinoma after hepatic resection	5
Appropriate definition of non-metastatic castration-resistant prostate cancer (nmCRPC) and optimal timing of androgen receptor signaling inhibitor (ARSI)	5
Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study	5
Evaluation of drug lag and drug loss in Japan: participation in global phase III oncology trials	5
Prognostic impact of dose reduced S-1 adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: a retrospective multicenter study	5
Risk of first onset of colorectal cancer associated with alcohol consumption in Lynch syndrome: a multicenter cohort study	5
Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs	5
The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy	5
Development and validation of neoadjuvant rectal score-based signature nomograms to predict overall survival and disease-free survival in locally advanced rectal cancer: a retrospective, double center	5
Correction to: Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncolo	5
PD-L1 expression and microsatellite instability (MSI) in cancer of unknown primary site	5
Correction to: Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan	5
Differences in efficacy of biweekly irinotecan plus cisplatin versus irinotecan alone in second-line treatment of advanced gastric cancer with or without prior gastrectomy	5
Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system	5
Correction to: COVID‑19 infection in pediatric patients treated for cancer	5
Lymphatic drainage patterns of malignant skin tumors in the head and neck region: a single-center retrospective study	5
Adjuvant taxane plus platinum chemotherapy for stage I ovarian clear cell carcinoma with complete surgical staging: are more than three cycles necessary?	5
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1	5
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study	5
Locomotive syndrome in cancer patients: a new role of orthopaedic surgeons as a part of comprehensive cancer care	5
The impact of the American Society of Anesthesiology-Physical Status classification system on the treatment and prognosis of patients with esophageal cancer undergoing esophagectomy	5
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma	5
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan	5
Current status and prospects of breast cancer imaging-based diagnosis using artificial intelligence	5
Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers	5
Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-anal	5
Intensity-modulated radiation therapy can reduce acute toxicities in long-course neoadjuvant radiation therapy combined with S-1 for locally advanced rectal cancer	5
Postoperative lymphocyst formation after pelvic lymphadenectomy for gynecologic cancers: comparison between laparoscopy and laparotomy	5
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer	5
Age-related genomic alterations and chemotherapy sensitivity in osteosarcoma: insights from cancer genome profiling analyses	5
Soft-tissue sarcoma in adolescents and young adults	5
Real-world outcomes in patients with metastatic castration-resistant prostate cancer beyond progression after upfront androgen receptor signaling inhibitor	5
Distant parenchymal recurrence during long-term use of TTFields treatment for glioblastoma	5
Computed tomography-derived biomarker for predicting the treatment response to neoadjuvant chemoradiotherapy of rectal cancer	5
Acid suppressants reduce the therapeutic effect of immune checkpoint inhibitors and increase the risk of acute kidney injury: a meta-analysis	5
Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents	5
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1	5
Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database	5
Clinical impact of cerebral infarction in patients with non-small cell lung cancer	5
Genomic medicine advances for brain tumors	5
Risk of mortality and other adverse outcomes from myocardial infarction in cancer survivors: a meta-analysis	5
Spatial and temporal patterns of colorectal cancer in Asia, 1990–2019	4